MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vesselsfor Coronary Artery Disease24 locations incl. GilbertSponsor: Concept Medical Inc.Sex: All·Age: 18 - 80Code: NCT06271590·RecruitingApply to this trial
GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissectionsfor Aortic Dissection18 locations incl. BirminghamSponsor: W.L.Gore & AssociatesSex: All·Age: 18+Code: NCT06827990·RecruitingApply to this trial
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infectionsfor Neutropenia22 locations incl. PhoenixSponsor: X4 PharmaceuticalsSex: All·Age: 12+Code: NCT06056297·Phase 3·RecruitingApply to this trial
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edemafor Macular Edema23 locations incl. ArcadiaSponsor: Boehringer IngelheimSex: All·Age: 18+Code: NCT06962839·Phase 2·RecruitingApply to this trial
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumorsfor Solid Tumor Malignancies13 locations incl. DenverSponsor: Tasca TherapeuticsSex: All·Age: 18+Code: NCT07030257·Phase 1, Phase 2·RecruitingApply to this trial
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsyfor Mesial Temporal Lobe Epilepsy18 locations incl. BirminghamSponsor: UniQure Biopharma B.V.Sex: All·Age: 18 - 75Code: NCT06063850·Phase 1, Phase 2·RecruitingApply to this trial
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancerfor Non-small Cell Lung Cancer22 locations incl. BirminghamSponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)Sex: All·Age: 18+Code: NCT06343402·Phase 1·RecruitingApply to this trial
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC)for Pancreatic Ductal Adenocarcinoma (PDAC)15 locations incl. CerritosSponsor: SOFIESex: All·Age: 18+Code: NCT07217717·Phase 3·RecruitingApply to this trial
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinomafor Renal Cell Carcinoma20 locations incl. TucsonSponsor: HiberCell, Inc.Sex: All·Age: 18+Code: NCT06234605·Phase 1·RecruitingApply to this trial
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.for Esophageal Cancer15 locations incl. CerritosSponsor: SOFIESex: All·Age: 18+Code: NCT07217704·Phase 3·RecruitingApply to this trial
Study of INCB123667 in Subjects With Advanced Solid Tumorsfor Solid TumorsDrug: INCB12366719 locations incl. DuarteSponsor: Incyte CorporationSex: All·Age: 18+Code: NCT05238922·Phase 1·RecruitingApply to this trial
A Study to Investigate the Safety and Efficacy of KQB168 as Monotherapy and in Combination in Participants With Advanced Solid Malignanciesfor Solid Tumor Malignancies15 locations incl. PhoenixSponsor: Kumquat Biosciences Inc.Sex: All·Age: 18+Code: NCT06994806·Phase 1·RecruitingApply to this trial
The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuationfor Supratentorial Hemorrhage20 locations incl. BurbankSponsor: Integra LifeSciences CorporationSex: All·Age: 18+Code: NCT04494295·RecruitingApply to this trial
A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis (gMG)for New Onset Generalized Myasthenia Gravis (gMG)Drug: Efgartigimod PH20 SC18 locations incl. La JollaSponsor: argenxSex: All·Age: 18+Code: NCT06909214·Phase 4·RecruitingApply to this trial
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumorsfor Advanced/Metastatic Solid Tumors23 locations incl. La JollaSponsor: Merus B.V.Sex: All·Age: 18+Code: NCT03526835·Phase 1, Phase 2·RecruitingApply to this trial
Study of NXC-201 CAR-T in Patients With Light Chain (AL) Amyloidosisfor Light Chain (AL) Amyloidosis18 locations incl. BerkeleySponsor: Nexcella Inc.Sex: All·Age: 18 - 120Code: NCT06097832·Phase 1, Phase 2·RecruitingApply to this trial
Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myelomafor Multiple Myeloma Refractory12 locations incl. San FranciscoSponsor: CellCentric Ltd.Sex: All·Age: 18+Code: NCT07096778·Phase 2·RecruitingApply to this trial
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomasfor Ewing Sarcoma23 locations incl. ScottsdaleSponsor: Inhibrx Biosciences, IncSex: All·Age: 12 - 85Code: NCT03715933·Phase 1·RecruitingApply to this trial
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)for Ulcerative Colitis14 locations incl. PhoenixSponsor: TakedaSex: All·Age: 2 - 17Code: NCT06405087·Phase 3·RecruitingApply to this trial
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungsfor Lung Cancer, Non-small Cell14 locations incl. DothanSponsor: Krystal Biotech, Inc.Sex: All·Age: 18+Code: NCT06228326·Phase 1, Phase 2·RecruitingApply to this trial
Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillationfor Atrial Fibrillation (AF)18 locations incl. BirminghamSponsor: Arga Medtech SASex: All·Age: 18 - 80Code: NCT06784466·RecruitingApply to this trial
A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)for Heart21 locations incl. Little RockSponsor: Vasa TherapeuticsSex: All·Age: 50+Code: NCT07219511·Phase 1·RecruitingApply to this trial
Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)for Aneurysm10 locations incl. TucsonSponsor: Stryker NeurovascularSex: All·Age: 18 - 80Code: NCT06872684·RecruitingApply to this trial
Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)for Low Risk Myelodysplastic Syndromes15 locations incl. Los AngelesSponsor: Rigel PharmaceuticalsSex: All·Age: 18+Code: NCT05308264·Phase 1, Phase 2·RecruitingApply to this trial
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)for Relapsed or Refractory Multiple Myeloma (RRMM)22 locations incl. BirminghamSponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb CompanySex: All·Age: 18+Code: NCT06615479·Phase 3·RecruitingApply to this trial
INHANCE Stemless Reverse Shoulder IDEfor Arthroplasty19 locations incl. IrvineSponsor: DePuy OrthopaedicsSex: All·Age: 22+Code: NCT06323980·RecruitingApply to this trial
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosumfor Pyoderma Gangrenosum21 locations incl. BirminghamSponsor: Boehringer IngelheimSex: All·Age: 18+Code: NCT06624670·Phase 3·RecruitingApply to this trial
Acellular Dermal Matrix Investigation in Breast Reconstructionfor Breast Reconstruction13 locations incl. Little RockSponsor: RTI SurgicalSex: Female·Age: 22+·Accepts healthy volunteersCode: NCT06456554·RecruitingApply to this trial
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumorsfor Cancer15 locations incl. Los AngelesSponsor: Krystal Biotech, Inc.Sex: All·Age: 18+Code: NCT05970497·Phase 1, Phase 2·RecruitingApply to this trial
CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)for Recurrent Pericarditis21 locations incl. PhoenixSponsor: Cardiol Therapeutics Inc.Sex: All·Age: 18+Code: NCT06708299·Phase 3·RecruitingApply to this trial
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancerfor Squamous Cell Carcinoma of Head and NeckDrug: Amivantamab15 locations incl. La JollaSponsor: Janssen Research & Development, LLCSex: All·Age: 18+Code: NCT06385080·Phase 1, Phase 2·RecruitingApply to this trial
Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphomafor Relapsed or Refractory T Cell Lymphoma20 locations incl. BirminghamSponsor: Ono Pharmaceutical Co., Ltd.Sex: All·Age: 18+Code: NCT05079282·Phase 1·RecruitingApply to this trial
TVMR With the INNOVALVE System Trial - Early Feasibility Studyfor Mitral Valve Regurgitation (Degenerative or Functional)20 locations incl. Los AngelesSponsor: Edwards LifesciencesSex: All·Age: 18+Code: NCT04919980·RecruitingApply to this trial
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)for Alpha 1 Antitrypsin Deficiency10 locations incl. BirminghamSponsor: Grifols Therapeutics LLCSex: All·Age: 18 - 80Code: NCT07555483·Phase 3·RecruitingApply to this trial
Study of INCA036978 in Participants With Myeloproliferative Neoplasmsfor Myeloproliferative NeoplasmsDrug: INCA03697822 locations incl. BirminghamSponsor: Incyte CorporationSex: All·Age: 18+Code: NCT07441694·Phase 1·RecruitingApply to this trial
A Study to Learn About the Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammationfor Microvascular Inflammation20 locations incl. Loma LindaSponsor: BiogenSex: All·Age: 18 - 74Code: NCT07219043·Phase 2·RecruitingApply to this trial
Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinomafor Low Grade Upper Tract Urothelial Carcinoma13 locations incl. AtlantaSponsor: Tyra Biosciences, IncSex: All·Age: 18+Code: NCT07265947·Phase 2·RecruitingApply to this trial
Gene Therapy for HER-Positive Cancer (SENTRY-HER2)for HER2 Expressing Solid Tumors10 locations incl. Los AngelesSponsor: Vironexis Biotherapeutics Inc.Sex: All·Age: 18+Code: NCT07192432·Phase 1, Phase 2·RecruitingApply to this trial
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphomafor Lymphoma14 locations incl. AuroraSponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb CompanySex: All·Age: 18+Code: NCT07015242·Phase 2·RecruitingApply to this trial
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myelomafor Relapsed/Refractory Multiple Myeloma16 locations incl. BirminghamSponsor: Caribou Biosciences, Inc.Sex: All·Age: 18+Code: NCT05722418·Phase 1·RecruitingApply to this trial